Candel Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

224.91M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	125.00K	-	-
Dec 31, 2021	125.00K	-	-
Dec 31, 2020	125.00K	-	-
Dec 31, 2019	125.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Nevro	426.10M
Nektar Therapeutics	93.16M
2seventy bio	44.12M
Cellectis	19.64M
Inhibrx Biosciences	1.69M

Revenue Rankings

CADL News

2 months ago - 3 Biotech Names With Potential Catalysts By Year End - Seeking Alpha
3 months ago - Candel Therapeutics to Join Russell 3000® Index - GlobeNewsWire
4 months ago - FDA Grants Orphan Drug Designation for CAN-3110 for the Treatment of Recurrent High-Grade Glioma - GlobeNewsWire
4 months ago - Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting - GlobeNewsWire
4 months ago - Candel Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
4 months ago - Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting - GlobeNewsWire
4 months ago - Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
5 months ago - Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting - GlobeNewsWire

More News